4
Changes in Ownership
CytoDyn Inc. Filed Acc 0001104659-24-032609
Options or other derivatives
- Chief Executive Officer acquired 3,000,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lalezari Jacob P Chief Executive Officer | 2024-03-07 | Grant or award · Non-qualified stock option (right to buy) | +3,000,000 | 3,000,000 | D: show line 1 in the form |
Loading xslF345X05/tm248303-1_4seq1.xml…